Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine: A phase 3 randomized clinical trial
<strong>Importance</strong> There is a need for improved immunogenicity of hepatitis B virus (HBV) vaccines among young adults with risk of infection. <br> <strong>Objectives</strong> To demonstrate manufacturing equivalence of a 3-antigen (3A) HBV vaccine, evaluate n...
প্রধান লেখক: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
অন্যান্য লেখক: | |
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
American Medical Association
2021
|